<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Rate of active TB and incidence rate ratio for latent TB tests in various risk groups</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Rate of active TB and incidence rate ratio for latent TB tests in various risk groups</h1>
<div class="graphic"><div class="figure"><div class="ttl">Rate of active TB and incidence rate ratio for latent TB tests in various risk groups</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="25%"></colgroup><colgroup span="4" width="12.5%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Population/clinical condition</td> <td class="subtitle1" rowspan="2">Test<br/> (criteria for positive TST)</td> <td class="subtitle1" colspan="2">Rate of TB<br/> (per 1000 person-years)</td> <td class="subtitle1" colspan="2">Incidence rate ratio<br/> (Incidence Test Positive)<br/> (Incidence Test Negative)</td> </tr> <tr> <td class="subtitle2">Estimate</td> <td class="subtitle2">95% CI</td> <td class="subtitle2">Estimate</td> <td class="subtitle2">95% CI</td> </tr> <tr> <td><strong>General population</strong> (no TB risk factors)</td> <td>TST (10 mm)</td> <td class="centered">0.3</td> <td class="centered">0.1 to 1.1</td> <td class="centered">–</td> <td class="centered">–</td> </tr> <tr> <td colspan="6"><strong>Contacts</strong></td> </tr> <tr> <td class="indent1" rowspan="3">All contacts</td> <td>IGRA</td> <td class="centered">13.3</td> <td class="centered">10.8 to 16.4</td> <td class="centered">8.4</td> <td class="centered">5.2 to 13.5</td> </tr> <tr> <td>TST (5 mm)</td> <td class="centered">8.4</td> <td class="centered">4.3 to 16.5</td> <td class="centered">12.5</td> <td class="centered">6.4 to 22.5</td> </tr> <tr> <td>TST (10 mm)</td> <td class="centered">9.4</td> <td class="centered">4.0 to 21.8</td> <td class="centered">6.9</td> <td class="centered">3.3 to 14.4</td> </tr> <tr> <td class="indent1" rowspan="3">Close contacts</td> <td>IGRA</td> <td class="centered">22.4</td> <td class="centered">12.1 to 41.8</td> <td class="centered">13.1</td> <td class="centered">3.3 to 51.9</td> </tr> <tr> <td>TST (5 mm)</td> <td class="centered">10.5</td> <td class="centered">7.7 to 14.3</td> <td class="centered">3.7</td> <td class="centered">2.1 to 6.5</td> </tr> <tr> <td>TST (10 mm)</td> <td class="centered">10.3</td> <td class="centered">6.1 to 17.4</td> <td class="centered">2.5</td> <td class="centered">1.3 to 4.8</td> </tr> <tr> <td colspan="6"><strong>Immunocompromised patients</strong></td> </tr> <tr> <td class="indent1" rowspan="2">HIV infection</td> <td>IGRA</td> <td class="centered">16.9</td> <td class="centered">10.5 to 27.3</td> <td class="centered">11.0</td> <td class="centered">4.6 to 26.2</td> </tr> <tr> <td>TST (5 mm)</td> <td class="centered">27.1</td> <td class="centered">15.0 to 49.0</td> <td class="centered">11.1</td> <td class="centered">6.2 to 19.9</td> </tr> <tr> <td class="indent1" rowspan="3">Dialysis</td> <td>IGRA</td> <td class="centered">3.4</td> <td class="centered">1.1 to 10.7</td> <td class="centered">7.0</td> <td class="centered">0.7 to 67.0</td> </tr> <tr> <td>TST (5 mm)</td> <td class="centered">11.8</td> <td class="centered">0.7 to 201.0</td> <td class="centered">1.5</td> <td class="centered">0.7 to 3.3</td> </tr> <tr> <td>TST (10 mm)</td> <td class="centered">100.8</td> <td class="centered">42.1 to 243.0</td> <td class="centered">2.6</td> <td class="centered">1.4 to 4.8</td> </tr> <tr> <td class="indent1" rowspan="3">Transplant recipients</td> <td>IGRA</td> <td class="centered">6.7</td> <td class="centered">2.2 to 20.4</td> <td class="centered">2.5</td> <td class="centered">1.0 to 6.0</td> </tr> <tr> <td>TST (5 mm)</td> <td class="centered">1.0</td> <td class="centered">0 to 64.0</td> <td class="centered">0.6</td> <td class="centered">0.1 to 3.0</td> </tr> <tr> <td>TST (10 mm)</td> <td class="centered">3.7</td> <td class="centered">0 to 862.0</td> <td class="centered">2.4</td> <td class="centered">0.9 to 6.4</td> </tr> <tr> <td class="indent1" rowspan="2">Other immunocompromising conditions</td> <td>IGRA</td> <td class="centered">4.8</td> <td class="centered">0.1 to 279.0</td> <td class="centered">48.1</td> <td class="centered">5.4 to 431.0</td> </tr> <tr> <td>TST (5 mm)</td> <td class="centered">5.4</td> <td class="centered">1.8 to 16.9</td> <td class="centered">6.6</td> <td class="centered">1.8 to 24.2</td> </tr> </tbody></table></div><div class="graphic_lgnd">The table summarizes data from a meta-analysis including 122 studies and 116,197 participants with a positive latent TB test (IGRA or TST). In general, among individuals with a given risk factor, those with positive IGRA had higher rates of active TB than those with positive TST, likely reflecting greater specificity of IGRA. Notably, the incidence rate ratios were 11.0 in patients with HIV infection regardless of LTBI test, underscoring the value of LTBI screening in this population.</div><div class="graphic_footnotes">TB: tuberculosis; 

	TST: tuberculin skin test; 

	IGRA: interferon-gamma release assay; 

	LTBI: latent TB infection.</div><div class="graphic_reference">Data from: Campbell JR, Winters N, Menzies D. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis. BMJ 2020; 368:m549.</div><div id="graphicVersion">Graphic 130580 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
